Intraoperative serum lactate is not a predictor of survival after glioblastoma surgery
Authors:
- 1 September 2017
- journal article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 43, 224-228
Abstract
No abstract availableKeywords
Funding Information
- CCSG (NCI P30 CA016672)
This publication has 20 references indexed in Scilit:
- The angiogenic switch leads to a metabolic shift in human glioblastomaNeuro-Oncology, 2016
- Association of early changes in1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimenNeuro-Oncology, 2016
- Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypesOncotarget, 2016
- Serum lactate as a potential biomarker of non-glial brain tumorsJournal of Clinical Neuroscience, 2015
- Serum lactate as a potential biomarker of malignancy in primary adult brain tumoursJournal of Clinical Neuroscience, 2015
- Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging†Neuro-Oncology, 2013
- Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survivalJournal of Neurosurgery, 2011
- Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastomaProceedings of the National Academy of Sciences, 2011
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBMJournal of Neuro-Oncology, 2008